$GRAL
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Robert Ragusa
CEO
1000
Employees
$48.47
Current Price
$3.77B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 6 | $617,286.76 | 12,890 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 15 | $3,955,044.22 | 79,294 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 15 | $3,955,044.22 | 79,294 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 15 | $3,955,044.22 | 79,294 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Freidin Aaron Chief Financial Officer | Sale | 655 | $53.01 | $34,721.55 | View Details |
| Mar 9, 2026 | Freidin Aaron Chief Financial Officer | Sale | 2,407 | $47.93 | $115,367.51 | View Details |
| Mar 9, 2026 | Freidin Aaron Chief Financial Officer | Sale | 85 | $46.74 | $3,972.90 | View Details |
| Mar 5, 2026 | Ofman Joshua J. President | Sale | 690 | $53.01 | $36,576.90 | View Details |
| Mar 9, 2026 | Ofman Joshua J. President | Sale | 2,836 | $47.93 | $135,929.48 | View Details |
| Mar 9, 2026 | Ofman Joshua J. President | Sale | 101 | $46.74 | $4,720.74 | View Details |
| Mar 5, 2026 | RAGUSA ROBERT P Director | Sale | 980 | $53.01 | $51,949.80 | View Details |
| Mar 9, 2026 | RAGUSA ROBERT P Director | Sale | 7,203 | $47.93 | $345,239.79 | View Details |
| Mar 9, 2026 | RAGUSA ROBERT P Director | Sale | 258 | $46.73 | $12,056.34 | View Details |
| Mar 2, 2026 | Ofman Joshua J. President | Sale | 779 | $51.75 | $40,313.95 | View Details |
| Mar 2, 2026 | Ofman Joshua J. President | Sale | 16,223 | $50.09 | $812,533.82 | View Details |
| Mar 2, 2026 | RAGUSA ROBERT P Director | Sale | 35,787 | $50.09 | $1,792,402.63 | View Details |
| Mar 2, 2026 | RAGUSA ROBERT P Director | Sale | 1,717 | $51.84 | $89,014.43 | View Details |
| Mar 2, 2026 | Freidin Aaron Chief Financial Officer | Sale | 9,135 | $50.09 | $457,529.22 | View Details |
| Mar 2, 2026 | Freidin Aaron Chief Financial Officer | Sale | 438 | $51.86 | $22,715.16 | View Details |
24 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$3.33
ActualN/A
Revenue
EstimatedN/A
ActualN/A